XML 49 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Revenue - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2020
Revenue and Concentration Risk [Line Items]          
Advance Medicare payments to provide relief from economic impacts of COVID-19         $ 29,700,000
Revenue (decrease) increase due to changes in estimated transaction price due to contractual adjustments $ (5,300,000)   $ 20,100,000    
Capitalized costs incurred to obtain or fulfill contract $ 0   $ 0    
Performance obligation estimate          
Revenue and Concentration Risk [Line Items]          
Change in earnings per share (dollars per share) $ (0.05)   $ 0.19    
Government contracts concentration risk | Medicare | Revenues          
Revenue and Concentration Risk [Line Items]          
Concentration risk (percent) 15.00% 17.00% 14.00% 17.00%